Amylyx Pharmaceuticals, Inc. AMLX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s invested capital?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported invested capital of $49.66M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s invested capital decreased by 65.3% year-over-year, from $143.04M to $49.66M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s invested capital?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s invested capital has grown at a -33.3% compound annual growth rate (CAGR), from $284.36M to $84.57M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).